Review
Nov 2026
Long-term safety of Etrasimod in ulcerative colitis: a comprehensive review.
M. Colwill, S. Honap, F. Magro et al.
· Expert Opinion on Drug Safet... · 0 citations
We have 2 of 644 papers
We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.
Not the right person? Other researchers publish under this name.
Lower circulating DHA may represent one metabolic pathway linking UPF intake to increased CD risk, apart from additive harm to metabolic depletion, which highlights potential targets for precision nutrition in CD prevention in future trials.
We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.